retatrutide triple hormone receptor agonist obesity Incretin (LY3437943) alleviates obesity-associated cancer progression retatrutide phase 2 trial obesity
Pay in 4 interest-free payments of $5.52 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
























